"uptake will be rapid and widespread '

Another few ann regarding other EU countries and Htx will hit the mid .20s and climb rapidly from there.

This could go to over $1.00 within months on a couple of good ann regarding sales and distribution rights.

Intus Healthcare?s managing director Martin Heller said that ?Intus is thrilled to be the first to offer this superior test for diagnosing early stage ovarian cancer to women in the UK. Ovarian cancer is notoriously difficult to diagnose and we expect OvPlex? will save many women?s lives. We are confident the uptake will be rapid and widespread throughout the UK"

This is a winning stock to own imo. Good Luck to all holders.